健康的衰老和与衰老相关的病:百岁老人的经验教训
Shinya Yamamoto1, Yasumichi Arai2, Tatsuaki Kosaka1
1Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Clinical kidney journal
|December 15, 2025
概括
百岁老人,即活到100岁的人,尽管衰老,但脏健康状况显著. 研究它们揭示了健康衰老和预防脏疾病的秘密,为未来的治疗提供了希望.
科学领域:
- 老年病学和科.
- 专注于老龄化人口和脏健康.
背景情况:
- 全球人口老龄化,与年龄相关的疾病增加.
- 健康老龄化和长寿是关键的优先事项.
- 百岁老人提供了一个特殊的长寿和健康老龄化的模式.
研究的目的:
- 为了检查百岁老人的功能和结构.
- 阐明调节内在衰老的机制.
- 在细胞和免疫衰老的背景下,了解与衰老相关的脏疾病的发病性.
主要方法:
- 对百岁老人的临床和遗传特征的分析.
- 在百岁老人中识别预后生物标志物.
- 对衰老中细胞和免疫衰老的最新研究进行审查.
主要成果:
- 百岁老人表现出对心血管疾病风险因素的抵抗力.
- 尽管慢性病 (CKD) 的患病率很高,但百岁以上的人很少进展到衰竭.
- 脏衰老与细胞和免疫衰老有关.
结论:
- 百岁以上的长寿可能涉及慢慢的心血管和衰老,受到生活方式,环境,遗传和文化的影响.
- 了解百岁老人的衰老机制,可以为预防策略提供信息.
- 研究结果为开发治疗衰老和相关疾病的治疗策略提供了洞察力.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
217
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217
Chronic Kidney Disease III: Interprofessional Care
320
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
320
Chronic Kidney Disease I: Introduction
541
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
541
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Chronic Kidney Disease II: Clinical Manifestations
522
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
522


